Pfizer Inc (PFE)
Sector: Healthcare
Industry: Pharmaceutical Preparations
Country: United States
Exchange: NYSE
Market cap: $157.54B
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Latest financial period: June 28, 2026
Filed with the SEC: August 4, 2026
Estimated earnings date: November 3, 2026
Profit #935 of 1484 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROE/ROA | 36.3% | 40.6% | 42.5% | 42.1% |
Growth #1335 of 1484 companies
Payout #685 of 1484 companies
Safety #842 of 1484 companies
Price #615 of 1484 companies
